user avatar
Daniel E Spratt
@DrSpratticus
The comments & viewpoints are my own and are not endorsed or necessarily representative of UH CMC, CWRU, NCCN, FDA, NCI, or NRG. They are my personal opinion.
Cleveland, OH
Joined October 2016
Posts
  • Pinned
    user avatar
    X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI
  • user avatar
    Incredibly proud and honored to be the next Chair of Radiation Oncology @UHhospitals @CWRUSOM. Thanks to their outstanding leadership to provide an opportunity for me that will truly be transformative for cancer care. @TedTeknosMD @DanSimonMD @LPonsky @ASTRO_org
    Amazing @DrSpratticus, well done buddy. ✊ Inspiring to see @UHhospitals assessing beyond chronological age for choosing a solid, bold and success-driver leader! Fasten seatbelts everyone, UH Seidman Cancer Center will be pushing boundaries! news.uhhospitals.org/news-releases/…
  • user avatar
    Most milestones dont sink in- this 1 really felt good. As a below avg highschool student who dropped out of college, to becoming a tenured full prof means a lot. Not the title or the tenure, but the symbol that drive, collaboration, and a good heart can take you far.
    Massive congratulations to a close colleague and friend who started at @UMichRadOnc in 2015 and immediately elevated our program, institution, and the care we provide. @DrSpratticus Full prof with tenure 🎤 🎈 🥂 💥 💪 🥳
  • user avatar
    One of the biggest responsibilities and honors in my career is to be named the new Chair of the @NCCN Prostate Cancer guidelines, with my amazing vice chair @sandysrimd. Thanks to amazing NCCN staff and the world class panel of experts for spending much of 2 days to thoughtfully
  • user avatar
    Rectal Cancer Patients May Not Need Radiation, Study Finds - The New York Times ⁦@nytimes⁩ feel free to DM me. As Chair of large Radiation Onc Department I would be happy to inform you of danger of the article for pts. Easy fix. Worth it to fix.
  • user avatar
    Incredibly honored. 5 years ago I would never have thought as a radonc I could help manage so many aspects of our cancer centers trial program. Today I realize that your specialty doesn’t matter if you know your stuff and strive for success for the patients who we work hard for
    Congratulations to @DrSpratticus on being 1 of 10 researchers around the country to be awarded a 2019 NCI Cancer Clinical Investigator Team Leadership Award! The award recognizes outstanding mid-career clinical investigators working to improve the lives of people with #cancer.
  • user avatar
    Years in the making...#MARCAP now online @TheLancetOncol. 1st IPD meta-analysis of every eligible RCT evaluating tx intensification with ADT with RT in localized PCa. Enormous thanks to @AmarUKishan and the lead biostatistician Dr. Yilun Sun from @CWRUSOM, dozens more. @RadoncUh
    https://www.sciencedirect.com/science/article/pii/S1470204521007051
  • user avatar
    Incredibly proud of ⁦@NicholasZaorsky⁩ who was just promoted to be a Full Professor with Tenure at ⁦@CWRUSOM⁩ and ⁦@UHhospitals⁩. Congrats on all you have accomplished. You elevate ⁦@RadOncUH⁩ and our field. ⁦@ASTRO_org
  • user avatar
    Closing out my 1st 8 months as Chair, and I was shocked to have pulled off ~20% growth already thanks to our amazing team. We have hired 27 ppl; new heads of physics, RTTs, Department Administrator, Residency Coordinator, multiple new Vice Chairs, many amazing staff and faculty!
  • user avatar
    It begins... To PGY5s to established clinicians + researchers, change is happening now @UHhospitals @caseccc. See attached pic, but in brief we are starting to recruit for 7 physician faculty positions. Growing and building the dream team! @ASTRO_org @ARRO_org @ACROresident
  • user avatar
    #astro25 @NRGonc Rtog 0924 trial on 2500 patients testing whole pelvic RT. Negative trial -OS no difference -PCSM no difference -DM no difference -BCR was not SS different with only 4% difference at 10 years. -toxicity increased 3 cooperative group trials now negative:
  • user avatar
    It is a huge honor to be the 1st radonc as a full standing member on the FDAs ODAC (I am at least told). Will try to fill 1% of @GUONCGarciaJA who did an amazing job as as Chair. Time for my odd obsession in biostats, surrogate endpoints, futility analyses, trial design and
    This Post is from a suspended account. Learn more
  • user avatar
    Tweetorial on our recently published paper in @NEJMEvidence on the development and validation of the 1st predictive biomarker to guide ADT use in prostate cancer. Enjoy! #PCSM @arteraAI @NRGonc @felixfengmd @DrHowardSandler @EdwardSchaeffer @prostatemd @AarmstrongDuke
    One of the most impactful projects I have been fortunate to be part of with many incredible collaborators, @felixfengmd , @NRGonc , @arteraAI all coming together to create the 1st validated predictive biomarker for ADT use in PCa. Big win for patients! @uhradonc @caseccc #PCSM
  • user avatar
    Is my brother not freaking amazing? Amazing!
    The 3 album covers I did this year. @Logic301, @070shake, & @KiDCuDi